How Etiome Is Redefining Preemptive Medicine with Scott Lipnick

A new episode of Data in Biotech is live!

Preemptive medicine is emerging as a new frontier in healthcare, and Scott Lipnick is helping define the category.

In this episode, Ross Katz speaks with Scott, Co-Founder and President of Etiome, and Origination Partner, Preemptive Health and Medicine at Flagship Pioneering, about using AI to forecast disease progression, identify stage-specific biomarkers, and deliver precision interventions before symptoms ever appear.

This conversation dives into how data-driven tools are shifting the paradigm from reactive to preemptive care, and what that means for data scientists working in biotech.

>> Why Etiome is focused on treating disease before symptoms emerge
>> How temporal biodynamics models are built using clinical and omic data
>> What role biomarkers play in confirming disease stage and guiding treatment
>> How Etiome’s platform is designed to be disease-agnostic
>> What venture creation looks like inside Flagship Pioneering

Listen now wherever you find your podcasts.

Apple Podcasts
Spotify
YouTube